|
DSP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.95660187840963E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.55580001606859E-09 |
| Normal-vs-Stage2 |
1.132390E-01 |
| Normal-vs-Stage3 |
1.041040E-04 |
| Normal-vs-Stage4 |
3.839100E-04 |
| Stage1-vs-Stage2 |
1.954590E-01 |
| Stage1-vs-Stage3 |
7.834000E-01 |
| Stage1-vs-Stage4 |
6.356800E-01 |
| Stage2-vs-Stage3 |
3.355400E-01 |
| Stage2-vs-Stage4 |
1.813030E-01 |
| Stage3-vs-Stage4 |
5.423600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17229559393195E-11 |
| Normal-vs-AfricanAmerican |
2.330500E-02 |
| Normal-vs-Asian |
3.921200E-03 |
| Caucasian-vs-AfricanAmerican |
6.053000E-01 |
| Caucasian-vs-Asian |
5.653000E-01 |
| AfricanAmerican-vs-Asian |
9.356000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07689999998095E-06 |
| Normal-vs-Female |
3.6103999789816E-09 |
| Male-vs-Female |
3.476400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.66629998687995E-09 |
| Normal-vs-Age(41-60Yrs) |
4.68880000004113E-06 |
| Normal-vs-Age(61-80Yrs) |
1.000990E-03 |
| Normal-vs-Age(81-100Yrs) |
8.660000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.890500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.276600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.895900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.992200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.851800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.514200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.950800E-01 |
| Classical-VS-Follicular |
1.87405646556726E-12 |
| Classical-VS-Other |
9.918600E-01 |
| Classical-VS-Normal |
1.65045754840776E-12 |
| Tall-VS-Follicular |
1.037420E-04 |
| Tall-VS-Other |
8.480600E-01 |
| Tall-VS-Normal |
3.967100E-04 |
| Follicular-VS-Other |
6.597100E-03 |
| Follicular-VS-Normal |
2.731600E-01 |
| Other-VS-Normal |
7.877500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.002800E-04 |
| Normal-vs-N1 |
1.686080E-02 |
| N0-vs-N1 |
5.091000E-01 |
|
|
